I like the look of Tuas (ASX: TUA) stock because the FY 2025 results showed good progress and the acquisition of M1 gives additional scale.
General Assembly “side event” compares recognising long COVID to push for ban on indoor smoking as next public health policy challenge.
Chrysos Corporation (ASX: C79) builds gold sample testing units which it leases to gold miners, and to minerals testing businesses. Its new PhotonAssay testing technology is aiming to replace the ...
In AI data centres, these racks host an array of the most densely constructed and advanced computer chips. Immersed in liquid coolant and fully firing, a single one of these racks in 2025 consumes an ...
Before I (GrowthGauge here) delve into the FY25 results, it is important to understand the history of events for KME. This article marks the anniversary of my coverage of KME stock, shown below. I ...
Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...
When I wrote about LaserBond (ASX:LBL) on July 14th for A Rich Life here, the share price was around 37 cents. At that time, I asked whether the market was undervaluing the business. I also pointed ...
Monash IVF (ASX: MVF) reported in FY25 results on Friday, showing a 6.7% increase in revenue vs FY24 to $271.9 million, and $25.7 million in net profit after tax (NPAT) vs a loss in FY24. The reported ...
Now, as bad as it seems, the above result was expected, and the market was well informed about it prior to these results, so I don’t think these numbers drove the share price decline from around $6 ...
The PEXA Group (ASX: PXA) share price has gained over 20% to around $15.75, since it announced its agreement with NatWest to implement its technology. This milestone comes after nearly two years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results